Anthony M Leander

Anthony LeAnder serves as a Contract Specialist within the RPO East office of the Department of Veterans Affairs, where he plays a pivotal role in executing complex procurements that advance veteran health outcomes through biomedical innovation. He manages the acquisition of high-complexity scientific services, including genomics, metabolomics, and bioinformatic analysis, primarily in support of the Million Veteran Program and precision medicine initiatives. His portfolio centers on laboratory testing, analytical instrumentation, and data-driven clinical research services, ensuring alignment with VA’s mission to enhance diagnostic capabilities and translational research infrastructure. LeAnder applies deep expertise in FAR-based acquisition strategies to deliver mission-critical capabilities while maintaining strict compliance with federal procurement regulations. LeAnder maintains sustained partnerships with leading scientific and technical vendors, including TEMPUS AI, INC, INFINITY BIOLOGIX LLC, BOOZ ALLEN HAMILTON INC, and METABOLON, INC., reflecting a preference for established providers with proven capabilities in advanced life sciences and analytical research. His contracting patterns demonstrate consistent engagement with firms possessing specialized expertise in genomic sequencing, metabolomic profiling, and clinical data analytics. These relationships are characterized by long-term performance, technical rigor, and adherence to stringent quality and data integrity standards required for federal biomedical research. While the majority of LeAnder’s acquisitions are unrestricted—reflecting a 90.9% No Set-Aside rate—he maintains a measurable commitment to small business participation, with approximately 9.1% of awards structured as Total Small Business Set-Asides under FAR 19.5. His socioeconomic contracting approach prioritizes capability over size, ensuring that qualified small businesses with niche technical expertise can compete for high-value scientific services without compromising mission outcomes. His primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 541380 (Testing Laboratories and Services), with additional activity in research and development for life sciences. He routinely acquires next-generation sequencing platforms, high-throughput analytical systems, and specialized laboratory testing services essential to VA’s cutting-edge biomedical research initiatives.